Brigitte Michelsen Selected Research

Brigitte Michelsen Research Topics

19	Psoriatic Arthritis 04/2024 - 01/2017
12	Axial Spondyloarthritis 04/2024 - 01/2020
10	Pain (Aches) 01/2024 - 01/2018
8	Rheumatoid Arthritis 01/2022 - 01/2017
7	Ankylosing Spondylitis 04/2024 - 01/2020
7	Fatigue 01/2024 - 01/2020
4	Arthritis (Polyarthritis) 02/2023 - 01/2022
4	Necrosis 11/2021 - 01/2017
3	Ulcerative Colitis 01/2023 - 01/2021
3	Crohn Disease (Crohn's Disease) 01/2023 - 01/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021 - 01/2021
2	Inflammation (Inflammations) 05/2021 - 11/2020
2	Arthralgia (Joint Pain) 05/2021 - 11/2017
1	Rheumatic Diseases (Rheumatism) 02/2023
1	Non-Radiographic Axial Spondyloarthritis 01/2023
1	Infections 01/2023
1	Uveitis 01/2023
1	Neoplasms (Cancer) 12/2022
1	Spondylarthritis (Spinal Arthritis) 11/2022
1	Acute Coronary Syndrome 01/2022
1	Joint Diseases (Joint Disease) 01/2020

18	Tumor Necrosis Factor InhibitorsIBA 05/2024 - 01/2020
13	Antirheumatic Agents (DMARD)IBA 01/2023 - 01/2017
7	C-Reactive ProteinIBA 04/2024 - 01/2018
7	secukinumabIBA 01/2024 - 01/2020
4	ametantrone (HAQ)IBA 01/2024 - 10/2022
3	Adalimumab (Humira)FDA Link 01/2023 - 01/2023
2	Prostaglandins AIBA 01/2024 - 11/2022
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 08/2022 - 05/2021
2	ORALIT (ORS)IBA 01/2022 - 01/2021
2	Infliximab (Remicade)FDA Link 12/2021 - 01/2021
2	1- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedioneIBA 05/2021 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 11/2017 - 01/2017
1	Ustekinumab (CNTO 1275)FDA Link 01/2023
1	tofacitinibIBA 01/2023
1	apremilastIBA 01/2023
1	ixekizumabIBA 01/2023
1	Etanercept (Enbrel)FDA Link 01/2023
1	Abatacept (Orencia)FDA Link 01/2023
1	insulin receptor-related receptor (IRR)IBA 12/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022
1	AntibodiesIBA 08/2022
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Rheumatoid FactorIBA 11/2020
1	Anti-Citrullinated Protein AntibodiesIBA 11/2020
1	golimumab FDA Link 01/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2017

5	Therapeutics 01/2023 - 11/2020